Projects
Targeting neural stem cells for major depressive disorder: studying the synergy between cannabinoid type 2 receptors and physical exercise (STEM-CARE)
Funded by Fundação para a Ciência e a Tecnologia (FCT)​
​​
Sara Xapelli - Principal Investigator
​
2025-2028
Funded by HORIZON Europe, HORIZON-WIDERA-2023-ACCESS-04-01 - Pathways to Synergies, Coordination and Support Action
​
Consortium involving Faculdade de Medicina da Universidade de Lisboa and Instituto de Medicina Molecular Joao Lobo Antunes (Portugal), Instytut Farmakologii Im. Jerzego Maja Polskiej Akademii Nauk (Poland), The Fundación de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (Spain), and Vilnius University Life Sciences Center (Lithuania).
​
Sara Xapelli - Principal Investigator @ FMUL
​
2024-2026
Funded by European Commission, Erasmus+, Cooperation partnerships in higher education (KA220-HED)
​
Consortium involving Jagiellonian University (Poland), Hospital del Mar Research Institute (Spain), Faculdade de Medicina da Universidade de Lisboa (Portugal), Universidad de Salamanca (Spain), and Institut du Fer à Moulin (France).
​
Sara Xapelli - Principal Investigator @ FMUL
​
2023-2025
Mitochondria function in Multiple Sclerosis: unravelling approaches for disease progression and remyelination​
Funded by Fundação para a Ciência e a Tecnologia (FCT)
Ref: PTDC/MED-NEU/7976/2020
​
Sara Xapelli ​- ​Co-Principal Investigator
​
2021-2024
New targets for neural plasticity and brain repair: potential of adult neural stem cells
International Brain Research Organization (IBRO) Early Career Award
​
Sara Xapelli - Principal Investigator
​
2022
Cannabinoid type 2 receptors as therapeutic targets in depression: role of adult neural stem cells
​International Society for Neurochemistry Career Development Grant
​
Sara Xapelli ​- Principal Investigator
​
2021-2022
New potential therapy for multiple sclerosis: a role for adenosine A2A receptors
Funded by Fundação para a Ciência e a Tecnologia (FCT)
Ref: Exploratory Project IF/01227/2015
​
Sara Xapelli - Principal Investigator
​
2017-2021
